Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00676923 · ClinicalTrials.gov registry record
Improving Diabetes After Bariatric Surgery
A clinical trial of Obesity and Diabetes, sponsored by University of Pittsburgh.
- Completed
- Registry status
- 63
- Enrollment target
- 5
- Study locations
NCT00676923: Completed study of Obesity and Diabetes, sponsored by University of Pittsburgh.
NCT00676923 is a study of Obesity and Diabetes that has completed, run by University of Pittsburgh. The registered enrollment target is 63 participants, below the 819-participant average among 1,053 other Obesity trials with a reported enrollment target (92% lower). The trial reports 5 study locations across 3 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00676923, a study of Obesity and Diabetes, has completed, sponsored by University of Pittsburgh.
- COMPLETED
- Registry status
- 63 participants
- Enrollment target
- 5
- Study locations
Study Summary
The goal of this project is to examine the physical mechanisms that contribute to improvements of glucose tolerance in type 2 diabetes mellitus (DM) following certain types of bariatric surgery.
Study Locations (5)
Oregon
- Legacy Good Samaritan Hospital - Portland
- Oregon Health and Science University - Portland
Washington
- University of Washington - Seattle
- Virginia Mason Medical Center - Seattle
Pennsylvania
- University of Pittsburgh Medical Center - Pittsburgh
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 63 participants |
| Start Date | 2008-03 |
| Est. Completion | 2012-10 |
What the finished NCT00676923 record still lists
NCT00676923 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 63 participants, a relatively small participant target, below the 819-participant average among 1,053 other Obesity trials with a reported enrollment target (92% lower).
The record links to 2 conditions, with Obesity appearing as the primary indexed condition, and to 0 interventions.
NCT00676923 lists 5 locations in 3 states (Oregon, Washington, Pennsylvania).
Frequently Asked Questions
What is clinical trial NCT00676923 about?
NCT00676923 is a clinical study titled "Improving Diabetes After Bariatric Surgery". The goal of this project is to examine the physical mechanisms that contribute to improvements of glucose tolerance in type 2 diabetes mellitus (DM) following certain types of bariatric surgery.
What is the current status of trial NCT00676923?
This trial is currently completed. The enrollment target is 63 participants. The study started on 2008-03. Estimated completion is 2012-10.
What conditions does trial NCT00676923 study?
This clinical trial studies the following conditions: Obesity, Diabetes.
Who is sponsoring clinical trial NCT00676923?
This trial is sponsored by University of Pittsburgh, which has 1,238 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00676923 being conducted?
This trial has 5 study locations across Oregon, Pennsylvania, Washington. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Obesity
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT00676923's enrollment target sits among peer trials
63 627th of 1053 higher than 423 of 1,053 other Obesity trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Obesity trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
A Hip Flexion Feedback System for Exercise Monitoring in Individuals With Osteoarthritis and Obesity
RECRUITING · Phase 1
-
Metabolic Adaptations to Weight Loss With and Without Exercise
RECRUITING · NA
-
Testing an Integrated PTSD and Weight Management Intervention: A Hybrid Type 1 Trial
RECRUITING · NA
-
TIRzepatide for the Treatment of Obesity in Patients With Atrial Fibrillation
RECRUITING · Phase 2
-
Tirzepatide: Reversal of Lipotoxicity and Adipose Tissue Dysfunction in Humans With Overweight/Obesity
RECRUITING · Phase 2
-
Tai Chi as a Novel Strategy to Increase Physical Activity Among Adults Pursuing Metabolic and Bariatric Surgery
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03383575 · 63 participants · Phase 2
Azacitidine and Enasidenib in Treating Patients With IDH2-Mutant Myelodysplastic Syndrome
- NCT04870944 · 63 participants · Phase 1
CBL0137 for the Treatment of Relapsed or Refractory Solid Tumors, Including CNS Tumors and Lymphoma
- NCT05031897 · 63 participants · Phase 2
Two Step Haplo With Radiation Conditioning
- NCT05312671 · 63 participants · Phase 2
Atezolizumab Plus Etoposide and Platinum in Small Cell Bladder Cancer
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia